Jia, Nan
Eli Lilly (United States)
2 papers on CoChatORCID 0000-0002-6317-269X
Most cited papers
- Verified
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program
Child, C. J., Zimmermann, A. G., Chrousos, G. P., Cummings, E., Deal, C. L., Hasegawa, T., Jia, N., Lawrence, S., Linglart, A., Loche, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism
Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments
Cited by 80
- Verified
Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study
Mo, D., Fleseriu, M., Qi, R., Jia, N., Child, C. J., Bouillon, R., & Hardin, D. S. (2015) · The Lancet Diabetes & Endocrinology
Growth Hormone and Insulin-like Growth FactorsBone health and osteoporosis research
Cited by 64
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free